{"id":711,"date":"2024-08-13T21:29:32","date_gmt":"2024-08-13T13:29:32","guid":{"rendered":"https:\/\/flcube.com\/?p=711"},"modified":"2024-10-13T21:58:23","modified_gmt":"2024-10-13T13:58:23","slug":"legend-biotech-ceo-addresses-biosecure-act-concerns-amid-q2-2024-earnings-report","status":"publish","type":"post","link":"https:\/\/flcube.com\/?p=711","title":{"rendered":"Legend Biotech CEO Addresses Biosecure Act Concerns Amid Q2 2024 Earnings Report"},"content":{"rendered":"\n

Legend Biotech Corporation (Nasdaq: LEGN<\/a>), a leading Chinese biopharmaceutical company, has released its financial results for the second quarter of 2024. Amidst recent speculation about potential implications from the U.S. Biosecure Act, CEO Ying Huang addressed concerns during the earnings call. The U.S. House of Representatives’ committee on China had previously requested an FBI investigation into GenScript Biotechnology Co., Ltd (HKG: 1548<\/a>) and its subsidiaries, including Legend Biotech, to evaluate any national security risks.<\/p>\n\n\n\n

In response to investor inquiries about the company’s stance and actions in light of these developments, Dr. Huang expressed confidence in Legend’s ability to navigate U.S. legislative challenges: “We have carefully evaluated the draft bill\u2026 And have been engaging with certain stakeholders in Washington DC, including the Committee and House Speaker’s office\u2026 At this point, we do not believe there will be any direct impact to Legend\u2026 we’re not too concerned that we’re the target of the Biosecure bill.”<\/p>\n\n\n\n

Dr. Huang was more reserved when discussing the possibility of Legend becoming a takeover target, especially after the company reportedly began considering offers and enlisted Centerview Partners for advisory support. He chose to focus on Legend’s positive trajectory, particularly its collaboration with global partner Janssen Biotech on the development of the chimeric antigen receptor (CAR) T cell therapy Carvykti (ciltacabtagene autoleucel; cilta-cel). The therapy is expanding into second-line use for multiple myeloma (MM), with trials for frontline use ongoing. Huang noted that the company is exploring various options to maximize shareholder value, suggesting that remaining independent is a viable strategy given its potential: “We certainly believe that there’s a lot of growth ahead of us and we remain confident in our current long-term strategy to realize the full potential of Carvykti,” said Huang.<\/p>\n\n\n\n

In Q2\u201924, Carvykti net sales reached approximately USD 186 million, marking an 18.5% year-on-year increase. Following the U.S. FDA and EU’s April approvals for Carvykti in the second-line setting for MM, the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) and Health Canada also granted approvals for the same indication during Q2. The growing demand for the drug indicates that scaling up manufacturing capacity is the key challenge for Legend and J&J at present.- Flcube.com<\/a><\/p>\n\n\n\n

<\/p>\n","protected":false},"excerpt":{"rendered":"

Legend Biotech Corporation (Nasdaq: LEGN), a leading Chinese biopharmaceutical company, has released its financial results…<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAownpewDA:productID":"","_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":false,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[7],"tags":[27,872,112,873],"class_list":["post-711","post","type-post","status-publish","format-standard","hentry","category-company","tag-finanical-reports","tag-hkg-1548","tag-legend-biotech","tag-nasdaq-legn"],"yoast_head":"\nLegend Biotech CEO Addresses Biosecure Act Concerns Amid Q2 2024 Earnings Report - Insight, China's Pharmaceutical Industry<\/title>\n<meta name=\"description\" content=\"Legend Biotech Corporation (Nasdaq: LEGN), a leading Chinese biopharmaceutical company, has released its financial results for the second quarter of 2024. Amidst recent speculation about potential implications from the U.S. Biosecure Act, CEO Ying Huang addressed concerns during the earnings call. The U.S. House of Representatives' committee on China had previously requested an FBI investigation into GenScript Biotechnology Co., Ltd (HKG: 1548) and its subsidiaries, including Legend Biotech, to evaluate any national security risks.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/flcube.com\/?p=711\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Legend Biotech CEO Addresses Biosecure Act Concerns Amid Q2 2024 Earnings Report\" \/>\n<meta property=\"og:description\" content=\"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM\" \/>\n<meta property=\"og:url\" content=\"https:\/\/flcube.com\/?p=711\" \/>\n<meta property=\"og:site_name\" content=\"Insight, China's Pharmaceutical Industry\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61566606313834\" \/>\n<meta property=\"article:published_time\" content=\"2024-08-13T13:29:32+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-10-13T13:58:23+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"1894\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Fineline Cube\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fineline Cube\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=711#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=711\"},\"author\":{\"name\":\"Fineline Cube\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\"},\"headline\":\"Legend Biotech CEO Addresses Biosecure Act Concerns Amid Q2 2024 Earnings Report\",\"datePublished\":\"2024-08-13T13:29:32+00:00\",\"dateModified\":\"2024-10-13T13:58:23+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=711\"},\"wordCount\":385,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"keywords\":[\"Finanical Reports\",\"HKG: 1548\",\"Legend Biotech\",\"NASDAQ: LEGN\"],\"articleSection\":[\"Company\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=711#respond\"]}],\"copyrightYear\":\"2024\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=711\",\"url\":\"https:\\\/\\\/flcube.com\\\/?p=711\",\"name\":\"Legend Biotech CEO Addresses Biosecure Act Concerns Amid Q2 2024 Earnings Report - Insight, China's Pharmaceutical Industry\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\"},\"datePublished\":\"2024-08-13T13:29:32+00:00\",\"dateModified\":\"2024-10-13T13:58:23+00:00\",\"description\":\"Legend Biotech Corporation (Nasdaq: LEGN), a leading Chinese biopharmaceutical company, has released its financial results for the second quarter of 2024. Amidst recent speculation about potential implications from the U.S. Biosecure Act, CEO Ying Huang addressed concerns during the earnings call. The U.S. House of Representatives' committee on China had previously requested an FBI investigation into GenScript Biotechnology Co., Ltd (HKG: 1548) and its subsidiaries, including Legend Biotech, to evaluate any national security risks.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=711#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=711\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=711#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/flcube.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Legend Biotech CEO Addresses Biosecure Act Concerns Amid Q2 2024 Earnings Report\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"name\":\"Insight, China's Pharmaceutical Industry\",\"description\":\"Fineline Insights, Pharma Clarity\",\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/flcube.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\",\"name\":\"Fineline Infomation and Technology\",\"alternateName\":\"Fineline Info & Tech\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"width\":2560,\"height\":1894,\"caption\":\"Fineline Infomation and Technology\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61566606313834\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\",\"name\":\"Fineline Cube\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"caption\":\"Fineline Cube\"},\"sameAs\":[\"https:\\\/\\\/flcube.com\"],\"url\":\"https:\\\/\\\/flcube.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Legend Biotech CEO Addresses Biosecure Act Concerns Amid Q2 2024 Earnings Report - Insight, China's Pharmaceutical Industry","description":"Legend Biotech Corporation (Nasdaq: LEGN), a leading Chinese biopharmaceutical company, has released its financial results for the second quarter of 2024. Amidst recent speculation about potential implications from the U.S. Biosecure Act, CEO Ying Huang addressed concerns during the earnings call. The U.S. House of Representatives' committee on China had previously requested an FBI investigation into GenScript Biotechnology Co., Ltd (HKG: 1548) and its subsidiaries, including Legend Biotech, to evaluate any national security risks.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/flcube.com\/?p=711","og_locale":"en_US","og_type":"article","og_title":"Legend Biotech CEO Addresses Biosecure Act Concerns Amid Q2 2024 Earnings Report","og_description":"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM","og_url":"https:\/\/flcube.com\/?p=711","og_site_name":"Insight, China's Pharmaceutical Industry","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61566606313834","article_published_time":"2024-08-13T13:29:32+00:00","article_modified_time":"2024-10-13T13:58:23+00:00","og_image":[{"width":2560,"height":1894,"url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","type":"image\/jpeg"}],"author":"Fineline Cube","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Fineline Cube","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/flcube.com\/?p=711#article","isPartOf":{"@id":"https:\/\/flcube.com\/?p=711"},"author":{"name":"Fineline Cube","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a"},"headline":"Legend Biotech CEO Addresses Biosecure Act Concerns Amid Q2 2024 Earnings Report","datePublished":"2024-08-13T13:29:32+00:00","dateModified":"2024-10-13T13:58:23+00:00","mainEntityOfPage":{"@id":"https:\/\/flcube.com\/?p=711"},"wordCount":385,"commentCount":0,"publisher":{"@id":"https:\/\/flcube.com\/#organization"},"keywords":["Finanical Reports","HKG: 1548","Legend Biotech","NASDAQ: LEGN"],"articleSection":["Company"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/flcube.com\/?p=711#respond"]}],"copyrightYear":"2024","copyrightHolder":{"@id":"https:\/\/flcube.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/flcube.com\/?p=711","url":"https:\/\/flcube.com\/?p=711","name":"Legend Biotech CEO Addresses Biosecure Act Concerns Amid Q2 2024 Earnings Report - Insight, China's Pharmaceutical Industry","isPartOf":{"@id":"https:\/\/flcube.com\/#website"},"datePublished":"2024-08-13T13:29:32+00:00","dateModified":"2024-10-13T13:58:23+00:00","description":"Legend Biotech Corporation (Nasdaq: LEGN), a leading Chinese biopharmaceutical company, has released its financial results for the second quarter of 2024. Amidst recent speculation about potential implications from the U.S. Biosecure Act, CEO Ying Huang addressed concerns during the earnings call. The U.S. House of Representatives' committee on China had previously requested an FBI investigation into GenScript Biotechnology Co., Ltd (HKG: 1548) and its subsidiaries, including Legend Biotech, to evaluate any national security risks.","breadcrumb":{"@id":"https:\/\/flcube.com\/?p=711#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/flcube.com\/?p=711"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/flcube.com\/?p=711#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/flcube.com\/"},{"@type":"ListItem","position":2,"name":"Legend Biotech CEO Addresses Biosecure Act Concerns Amid Q2 2024 Earnings Report"}]},{"@type":"WebSite","@id":"https:\/\/flcube.com\/#website","url":"https:\/\/flcube.com\/","name":"Insight, China's Pharmaceutical Industry","description":"Fineline Insights, Pharma Clarity","publisher":{"@id":"https:\/\/flcube.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/flcube.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/flcube.com\/#organization","name":"Fineline Infomation and Technology","alternateName":"Fineline Info & Tech","url":"https:\/\/flcube.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/","url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","width":2560,"height":1894,"caption":"Fineline Infomation and Technology"},"image":{"@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61566606313834"]},{"@type":"Person","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a","name":"Fineline Cube","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","caption":"Fineline Cube"},"sameAs":["https:\/\/flcube.com"],"url":"https:\/\/flcube.com\/?author=1"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/711","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=711"}],"version-history":[{"count":3,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/711\/revisions"}],"predecessor-version":[{"id":6210,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/711\/revisions\/6210"}],"wp:attachment":[{"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=711"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=711"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=711"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}